The invention provides modified apelin polypeptides having increased stability, circulating half-life, and/or potency relative to the native apelin-13 polypeptide. Compositions comprising the modified apelin polypeptides and methods of using the polypeptides for treating cardiac disorders, such as heart failure, are also disclosed.
本发明提供了相对于原生凋亡素-13
多肽具有更高的稳定性、循环半衰期和/或效力的修饰凋亡素
多肽。本发明还公开了包含经修饰的凋亡
磷多肽的组合物以及使用该
多肽治疗心脏疾病(如心力衰竭)的方法。